Description
Global Cardiopulmonary Resuscitation Market Research Report—Forecast till 2027
Market Overview
According to this report, Global Cardiopulmonary Resuscitation Market accounted for USD 1,603.16 Million in 2019 and is anticipated to exhibit a CAGR of 10.50% during the review period of 2020 to 2027. Cardiopulmonary revival (CPR) is a lifesaving method helpful in numerous crises, including a respiratory failure or close suffocating, in which somebody’s breathing or heartbeat has halted. During a heart failure, due to an inadequate inventory of blood, the heart quits pulsating. In such conditions, blood flow imperative to supporting life can be given by continually packing the heart through an actual power applied to the patient’s chest. This salvage strategy is named cardiopulmonary revival (CPR), which is utilized in crises or conditions to shield the patient from deadly myocardial localized necrosis or cerebrum harm.
Global Cardiopulmonary Resuscitation Market is expected to register significant market growth owing to the rising prevalence of heart and respiratory diseases, rising geriatric population, rise in government initiatives, increasing global incidence of cancer, and increasing product approvals by major players. The market is expected to expand due to the increasing awareness regarding medical devices and key measures taken by government bodies in the adoption of monitoring devices and improving emergency paramedical services.
Market Segmentation
Global Cardiopulmonary Resuscitation Market has been categorized into Product Type, Compressor Type, Application, and End User.
Based on Product Type, the market is segmented into piston CPR devices, load-distributing band (LDB), active compression-decompression (ACD) devices and impedance threshold device, extracorporeal techniques, and invasive perfusion devices, and others. In terms of compressor type, the market is segmented into manual CPR and automatic mechanical CPR.
Based on application type, the global cardiopulmonary resuscitation market is classified into emergency departments, coronary & intensive care units, organ transplant facilities, air medevac units, and EMT rescue units. In terms of end-user, the market is classified into hospitals and clinics, cardiac catheterization laboratories, organ transplant units, and others.
Regional Analysis
Geographically, Global Cardiopulmonary Resuscitation Market has been classified into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is likely to command the largest market share owing to the increase in the prevalence of lifestyle diseases and heart diseases.
Europe is expected to contribute to the second largest market of the global cardiopulmonary resuscitation owing to the technological advancements, high disposable income, growing geriatric population, and favorable regulatory framework. Asia-Pacific is set to drive the third-largest share of the global market owing to the rising geriatric population, growing chronic diseases, and elevated utilization of medical devices in healthcare.
Major Players
The Key Players in the Global Cardiopulmonary Resuscitation Market are Stryker, Nihon Kohden Corporation, ZOLL Medical Corporation, Koninklijke Philips N.V., Vyaire Medical, Inc., General Electric Company, CPR Medical Devices, Inc., Michigan Instruments, Corpuls, SCHILLER, and Medtronic.
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
Table of Contents
TABLE OF CONTENT
1 EXECUTIVE SUMMARY
1.1 OVERVIEW 17
1.1.1 MARKET SYNOPSIS 18
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY 19
2.2 RESEARCH OBJECTIVE 19
2.3 LIST OF ASSUMPTIONS 20
3 RESEARCH METHODOLOGY
3.1 OVERVIEW 21
3.2 DATA MINING 21
3.3 SECONDARY RESEARCH 22
3.4 PRIMARY RESEARCH 23
3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 23
3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 24
3.5 FORECASTING TECHNIQUES 24
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 25
3.6.1 BOTTOM-UP APPROACH 26
3.6.2 TOP-DOWN APPROACH 27
3.7 DATA TRIANGULATION 27
3.8 VALIDATION 28
4 MARKET DYNAMICS
4.1 OVERVIEW 29
4.2 DRIVERS 30
4.2.1 INCREASING PREVALENCE OF HEART AND RESPIRATORY DISEASES 30
4.2.2 RISING GERIATRIC POPULATION 30
4.2.3 RISE IN GOVERNMENT INITIATIVES 31
4.3 RESTRAINTS 32
4.3.1 INEFFICIENCY OF MANUAL CPR DEVICES 32
4.4 OPPORTUNITIES 33
4.4.1 AUTOMATED CPR DEVICES 33
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS 34
5.1.1 R&D AND DESIGNING 35
5.1.2 MANUFACTURING 35
5.1.3 DISTRIBUTION 35
5.1.4 MARKETING & SALES 35
5.1.1 POST-SALES MONITORING 35
5.2 PORTER’S FIVE FORCES MODEL 36
5.2.1 BARGAINING POWER OF SUPPLIERS 37
5.2.2 BARGAINING POWER OF BUYERS 37
5.2.3 THREAT OF NEW ENTRANTS 37
5.2.4 THREAT OF SUBSTITUTES 37
5.2.5 INTENSITY OF RIVALRY 37
6 GLOBAL CARDIOPULMONARY RESUSCITATION MARKET, BY PRODUCT TYPE
6.1 OVERVIEW 38
6.2 PISTON CPR DEVICES 40
6.3 LOAD-DISTRIBUTING BAND (LDB) 41
6.4 ACTIVE COMPRESSION-DECOMPRESSION AND IMPEDANCE THRESHOLD DEVICE (ACD + ITD) 42
6.5 EXTRACORPOREAL TECHNIQUES AND INVASIVE PERFUSION DEVICES 43
6.6 OTHERS 43
7 GLOBAL CARDIOPULMONARY RESUSCITATION MARKET, BY COMPRESSOR TYPE
7.1 OVERVIEW 45
7.2 AUTOMATIC MECHANICAL CPR 46
7.2.1 BATTERY DRIVEN 47
7.2.2 PNEUMATIC DRIVEN 48
7.2.3 MECHANICALLY ACTUATED AND BATTERY DRIVEN 48
7.3 MANUAL CPR 48
8 GLOBAL CARDIOPULMONARY RESUSCITATION MARKET, BY APPLICATION
8.1 OVERVIEW 50
8.2 EMT RESCUE UNITS 51
8.3 CORONARY & INTENSIVE CARE UNITS 52
8.4 EMERGENCY DEPARTMENTS 53
8.5 ORGAN TRANSPLANT FACILITIES 53
8.6 AIR MEDEVAC UNITS 54
8.7 OTHERS 55
9 GLOBAL CARDIOPULMONARY RESUSCITATION MARKET, BY END USER
9.1 OVERVIEW 56
9.2 HOSPITAL & CLINIC 57
9.3 CARDIAC CATHETERIZATION LABORATORIES 58
9.4 ORGAN TRANSPLANT UNIT 58
9.5 OTHERS 59
10 GLOBAL CARDIOPULMONARY RESUSCITATIONMARKET, BY REGION
10.1 OVERVIEW 60
10.2 AMERICAS 61
10.2.1 NORTH AMERICA 64
10.2.1.1 US 67
10.2.1.2 CANADA 69
10.2.2 LATIN AMERICA 71
10.3 EUROPE 73
10.3.1 WESTERN EUROPE 76
10.3.1.1 GERMANY 80
10.3.1.2 UK 82
10.3.1.3 SPAIN 84
10.3.1.4 ITALY 86
10.3.1.5 FRANCE 88
10.3.1.6 REST OF WESTERN EUROPE 90
10.3.2 EASTERN EUROPE 92
10.4 ASIA-PACIFIC 94
10.4.1 CHINA 98
10.4.2 JAPAN 100
10.4.3 INDIA 102
10.4.4 AUSTRALIA 104
10.4.5 SOUTH KOREA 106
10.4.6 REST OF ASIA-PACIFIC 108
10.5 MIDDLE EAST & AFRICA 110
10.5.1 MIDDLE EAST 113
10.5.2 AFRICA 115
11 COMPETITIVE LANDSCAPE: GLOBAL CARDIOPULMONARY RESUSCITATION MARKET
11.1 OVERVIEW 118
11.2 MARKET RANKING ANALYSIS 118
11.3 COMPETITIVE BENCHMARKING 119
11.4 MAJOR GROWTH STRATEGIES IN THE GLOBAL CARDIOPULMONARY RESUSCITATION MARKET 120
11.5 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 121
11.6 KEY DEVELOPMENTS AND GROWTH STRATEGIES 121
11.6.1 EXPANSIONS 122
11.6.2 ACQUISITIONS 122
11.6.3 PRODUCT APPROVALS/LAUNCHES 123
11.7 MAJOR PLAYERS FINANCIAL MATRIX & MARKET RATIO 123
11.7.1 SALES & OPERATING PROFIT MARGIN 123
11.7.2 R&D EXPENDITURE 124
12 COMPANY PROFILES
12.1 ZOLL MEDICAL CORPORATION 125
12.1.1 COMPANY OVERVIEW 125
12.1.2 FINANCIAL OVERVIEW 126
12.1.3 PRODUCTS/SERVICES OFFERED 126
12.1.4 KEY DEVELOPMENTS 127
12.1.5 SWOT ANALYSIS 127
12.1.6 KEY STRATEGIES 127
12.2 STRYKER 128
12.2.1 COMPANY OVERVIEW 128
12.2.2 FINANCIAL OVERVIEW 128
12.2.3 PRODUCTS/SERVICES OFFERED 129
12.2.4 KEY DEVELOPMENTS 129
12.2.5 SWOT ANALYSIS 130
12.2.6 KEY STRATEGIES 130
12.3 NIHON KOHDEN 131
12.3.1 COMPANY OVERVIEW 131
12.3.2 FINANCIAL OVERVIEW 131
12.3.3 PRODUCTS/SERVICES OFFERED 132
12.3.4 KEY DEVELOPMENTS 132
12.3.5 SWOT ANALYSIS 133
12.3.6 KEY STRATEGIES 133
12.4 KONINKLIJKE PHILIPS N.V. 134
12.4.1 COMPANY OVERVIEW 134
12.4.2 FINANCIAL OVERVIEW 135
12.4.3 PRODUCTS/SERVICES OFFERED 135
12.4.4 KEY DEVELOPMENTS 135
12.4.5 SWOT ANALYSIS 136
12.4.6 KEY STRATEGIES 136
12.5 GE HEALTHCARE 137
12.5.1 COMPANY OVERVIEW 137
12.5.2 FINANCIAL OVERVIEW 137
12.5.3 PRODUCTS/SERVICES OFFERED 138
12.5.4 KEY DEVELOPMENTS 138
12.5.5 SWOT ANALYSIS 138
12.5.6 KEY STRATEGIES 138
12.6 VYAIRE MEDICAL, INC. 139
12.6.1 COMPANY OVERVIEW 139
12.6.2 FINANCIAL OVERVIEW 139
12.6.3 PRODUCTS/SERVICES OFFERED 139
12.6.4 KEY DEVELOPMENTS 139
12.6.5 SWOT ANALYSIS 140
12.6.6 KEY STRATEGIES 140
12.7 CPR MEDICAL DEVICES, INC. 141
12.7.1 COMPANY OVERVIEW 141
12.7.2 FINANCIAL OVERVIEW 141
12.7.3 PRODUCTS/SERVICES OFFERED 141
12.7.4 KEY DEVELOPMENTS 141
12.7.5 SWOT ANALYSIS 142
12.7.6 KEY STRATEGIES 142
12.8 MICHIGAN INSTRUMENTS 143
12.8.1 COMPANY OVERVIEW 143
12.8.2 FINANCIAL OVERVIEW 143
12.8.3 PRODUCTS/SERVICES OFFERED 143
12.8.4 KEY DEVELOPMENTS 143
12.8.5 SWOT ANALYSIS 144
12.8.6 KEY STRATEGIES 144
12.9 CORPULS 145
12.9.1 COMPANY OVERVIEW 145
12.9.2 FINANCIAL OVERVIEW 145
12.9.3 PRODUCTS/SERVICES OFFERED 145
12.9.4 KEY DEVELOPMENTS 145
12.9.5 SWOT ANALYSIS 146
12.9.6 KEY STRATEGIES 146
12.10 SCHILLER 147
12.10.1 COMPANY OVERVIEW 147
12.10.2 FINANCIAL OVERVIEW 147
12.10.3 PRODUCTS/SERVICES OFFERED 147
12.10.4 KEY DEVELOPMENTS 147
12.10.5 SWOT ANALYSIS 148
12.10.6 KEY STRATEGIES 148
12.11 MEDTRONIC 149
12.11.1 COMPANY OVERVIEW 149
12.11.2 FINANCIAL OVERVIEW 150
12.11.3 PRODUCTS/SERVICES OFFERED 150
12.11.4 KEY DEVELOPMENTS 150
12.11.5 SWOT ANALYSIS 151
12.11.6 KEY STRATEGIES 151
13 APPENDIX
13.1 REFERENCES 152
13.2 RELATED REPORTS 152
Reviews
There are no reviews yet.